| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,847 | 26,171 | 31,203 | 37,202 | | Cost of Revenue | 5,485 | 9,904 | 8,587 | 10,832 | | | Gross Profit | 18,362 | 16,267 | 22,616 | 26,370 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,633 | 6,361 | 7,900 | 5,517 | | Non Recurring | 2,091 |
-
| 216,391 | 178,470 | | Others | 12,603 | 12,324 | 15,347 | 16,418 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,874) | (2,418) | (217,022) | (174,035) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82 | (2,301) | 28,050 | 37,827 | | Earnings Before Interest And Taxes | (3,883) | (4,719) | (188,972) | (136,208) | | Interest Expense | 4,907 | 4,536 | 4,109 | 4,247 | | Income Before Tax | (8,790) | (9,255) | (193,081) | (140,455) | | Income Tax Expense | (3,994) | (3,239) | (67,536) | (47,127) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,796) | (6,016) | (125,545) | (93,328) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,796) | (6,016) | (125,545) | (93,328) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,796) | ($6,016) | ($125,545) | ($93,328) |
|
0.11% Nasdaq 
Income Statement
